Hashimoto thyroiditis: Clinical and diagnostic criteria

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 391-397

  Caturegli, P ^a,b   De Remigis, A ^a   Rose, N R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoimmunity; Hashimoto; Thyroiditis

Indexed keywords

GLUCOCORTICOID; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROXINE;

AMNESIA; ANEMIA; BILE DUCT STONE; BRADYCARDIA; BRADYPNEA; CARDIOMEGALY; CLINICAL FEATURE; CONSTIPATION; DEPRESSION; DIET SUPPLEMENTATION; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GOITER; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; HYPOXIA; ILEUS; LUNG COMPLIANCE; MUSCLE CRAMP; MYALGIA; OLIGOMENORRHEA; PLEURA EFFUSION; REVIEW; THYROID FUNCTION TEST; THYROIDECTOMY;

AUTOIMMUNITY; HASHIMOTO; THYROIDITIS;

ANIMALS; ANTIBODIES; FIBROSIS; HASHIMOTO DISEASE; HUMANS; THYROGLOBULIN; THYROID GLAND;

EID: 84896319312     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.007     Document Type: Review

References (79)

1. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243.
2. McLeod D.S., Cooper D.S. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012, 42:252-265.
3. Golden S.H., Robinson K.A., Saldanha I., Anton B., Ladenson P.W. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009, 94:1853-1878.
4. Delemer B., Aubert J.P., Nys P., Landron F., Bouee S. An observational study of the initial management of hypothyroidism in France: the ORCHIDEE study. Eur J Endocrinol 2012, 167:817-823.
5. Vanderpump M.P. The epidemiology of thyroid disease. Br Med Bull 2011, 99:39-51.
6. Caturegli P., De Remigis A., Chuang K., Dembele M., Iwama A., Iwama S. Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 2013, 23:142-150.
7. Li Y., Bai Y., Liu Z., Ozaki T., Taniguchi E., Mori I., et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int 2009, 59:636-641.
8. De Luca F., Santucci S., Corica D., Pitrolo E., Romeo M., Aversa T. Hashimoto's thyroiditis in childhood: presentation modes and evolution over time. Ital J Pediatr 2013, 39:8.
9. Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab 2012, 97:334-342.
10. Konturek A., Barczynski M., Wierzchowski W., Stopa M., Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 2013, 398:389-394.
11. Mandac J.C., Chaudhry S., Sherman K.E., Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006, 43:661-672.
12. Corsello S.M., Barnabei A., Marchetti P., De Vecchis L., Salvatori R., Torino F. Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab 2013, 98:1361-1375.
13. Vita R., Guarneri F., Agah R., Benvenga S. Autoimmune thyroid disease elicited by NY-ESO-1 vaccination. Thyroid 2013, (Epub ahead of print).
14. Cardenas-Roldan J., Rojas-Villarraga A., Anaya J.M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 2013, 11:73.
15. Vladutiu A.O., Rose N.R. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 1971, 174:1137-1139.
16. Grumet F.C., Coukell A., Bodmer J.G., Bodmer W.F., McDevitt H.O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med 1971, 285:193-196.
17. Simmonds M.J., Gough S.C. The search for the genetic contribution to autoimmune thyroid disease: the never ending story?. Brief Funct Genomics 2011, 10:77-90.
18. Hahsimoto H. Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir Ver Dtsch Z Chir 1912, 219-248.
19. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43:55-68.
20. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489-499.
21. Wiersinga W.M. Smoking and thyroid. Clin Endocrinol (Oxf) 2013, 79:145-151.
22. Andersen S.L., Olsen J., Wu C.S., Laurberg P. Smoking reduces the risk of hypothyroidism and increases the risk of hyperthyroidism: evidence from 450842 mothers giving birth in Denmark. Clin Endocrinol (Oxf) 2013, 80:307-314.
23. Belin R.M., Astor B.C., Powe N.R., Ladenson P.W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004, 89:6077-6086.
24. Carle A., Bulow Pedersen I., Knudsen N., Perrild H., Ovesen L., Banke Rasmussen L., et al. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clin Endocrinol (Oxf) 2012, 77:764-772.
25. Effraimidis G., Strieder T.G., Tijssen J.G., Wiersinga W.M. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol 2011, 164:107-113.
26. Effraimidis G., Tijssen J.G., Wiersinga W.M. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab 2009, 94:1324-1328.
27. Mannisto T., Hartikainen A.L., Vaarasmaki M., Bloigu A., Surcel H.M., Pouta A., et al. Smoking and early pregnancy thyroid hormone and anti-thyroid antibody levels in euthyroid mothers of the Northern Finland Birth Cohort 1986. Thyroid 2012, 22:944-950.
28. Mehran L., Amouzgar A., Delshad H., Azizi F. The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Exp Clin Endocrinol Diabetes 2012, 120:80-83.
29. Pedersen I.B., Laurberg P., Knudsen N., Jorgensen T., Perrild H., Ovesen L., et al. Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur J Endocrinol 2008, 158:367-373.
30. Strieder T.G., Prummel M.F., Tijssen J.G., Endert E., Wiersinga W.M. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003, 59:396-401.
31. Caturegli P., De Remigis A., Ferlito M., Landek-Salgado M.A., Iwama S., Tzou S.C., et al. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology 2012, 153:4580-4587.
32. Teng W., Shan Z., Teng X., Guan H., Li Y., Teng D., et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006, 354:2783-2793.
33. Teng X., Shan Z., Chen Y., Lai Y., Yu J., Shan L., et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 2011, 164:943-950.
34. Bjergved L., Jorgensen T., Perrild H., Carle A., Cerqueira C., Krejbjerg A., et al. Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr study. J Clin Endocrinol Metab 2012, 97:4022-4029.
35. Carayanniotis G. Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones (Athens) 2011, 10:27-35.
36. Barin J.G., Talor M.V., Sharma R.B., Rose N.R., Burek C.L. Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse. Clin Exp Immunol 2005, 142:251-259.
37. Kong Y.C., McCormick D.J., Wan Q., Motte R.W., Fuller B.E., Giraldo A.A., et al. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination. J Immunol 1995, 155:5847-5854.
38. Guaraldi F., Zang G., Dackiw A.P., Caturegli P. Oncocytic mania: a review of oncocytic lesions throughout the body. J Endocrinol Invest 2011, 34:383-394.
39. Caturegli P., Ruggere C. Karl Hurthle! Now, who was he?. Thyroid 2005, 15:121-123.
40. Katz S.M., Vickery A.L. The fibrous variant of Hashimoto's thyroiditis. Hum Pathol 1974, 5:161-170.
41. Li Y., Nishihara E., Hirokawa M., Taniguchi E., Miyauchi A., Kakudo K. Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 2010, 95:1309-1317.
42. Li Y., Zhou G., Ozaki T., Nishihara E., Matsuzuka F., Bai Y., et al. Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol 2012, 25:1086-1097.
43. Brain L., Jellinek E.H., Ball K. Hashimoto's disease and encephalopathy. Lancet 1966, 2:512-514.
44. Matsunaga A., Ikawa M., Fujii A., Nakamoto Y., Kuriyama M., Yoneda M. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol 2013, 69:14-20.
45. Liu M.Y., Zhang S.Q., Hao Y., Zheng H.M. Paroxysmal kinesigenic dyskinesia as the initial symptom of Hashimoto encephalopathy. CNS Neurosci Ther 2012, 18:271-273.
46. Wang J., Zhang J., Xu L., Shi Y., Wu X., Guo Q. Cognitive impairments in Hashimoto's encephalopathy: a case-control study. PloS one 2013, 8:e55758.
47. Tang Y., Xing Y., Lin M.T., Zhang J., Jia J. Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol 2012, 12:60.
48. Demirbilek H., Kandemir N., Gonc E.N., Ozon A., Alikasifoglu A., Yordam N. Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab 2007, 20:1199-1205.
49. Rallison M.L., Dobyns B.M., Keating F.R., Rall J.E., Tyler F.H. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr 1975, 86:675-682.
50. Wasniewska M., Corrias A., Salerno M., Mussa A., Capalbo D., Messina M.F., et al. Thyroid function patterns at Hashimoto's thyroiditis presentation in childhood and adolescence are mainly conditioned by patients' age. Horm Res Paediatr 2012, 78:232-236.
51. Fatourechi V., McConahey W.M., Woolner L.B. Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clin Proc 1971, 46:682-689.
52. Wasniewska M., Corrias A., Salerno M., Lombardo F., Aversa T., Mussa A., et al. Outcomes of children with hashitoxicosis. Horm Res Paediatr 2012, 77:36-40.
53. Nishimaki M., Isozaki O., Yoshihara A., Okubo Y., Takano K. Clinical characteristics of frequently recurring painless thyroiditis: contributions of higher thyroid hormone levels, younger onset, male gender, presence of thyroid autoantibody and absence of goiter to repeated recurrence. Endocr J 2009, 56:391-397.
54. Man E.B., Jones W.S., Holden R.H., Mellits E.D. Thyroid function in human pregnancy. 8. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function. Am J Obstet Gynecol 1971, 111:905-916.
55. Glinoer D., Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000, 10:871-887.
56. Lazarus J.H., Ammari F., Oretti R., Parkes A.B., Richards C.J., Harris B. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997, 47:305-308.
57. Pandit A.A., Vijay Warde M., Menon P.S. Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis. Diagn Cytopathol 2003, 28:63-65.
58. McLachlan S.M., Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?. Thyroid 2004, 14:510-520.
59. Carle A., Laurberg P., Knudsen N., Perrild H., Ovesen L., Rasmussen L.B., et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity 2006, 39:497-503.
60. Rose N.R. Autoimmune escalation: through the crystal ball. Clin Exp Immunol 2007, 147:9.
61. Chen C.R., Hamidi S., Braley-Mullen H., Nagayama Y., Bresee C., Aliesky H.A., et al. Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology 2010, 151:4583-4593.
62. Hutfless S., Matos P., Talor M.V., Caturegli P., Rose N.R. Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab 2011, 96:E1466-E1471.
63. Lee J.H., Anzai Y. Imaging of thyroid and parathyroid glands. Semin Roentgenol 2013, 48:87-104.
64. Koprowski R., Zieleznik W., Wrobel Z., Malyszek J., Stepien B., Wojcik W. Assessment of significance of features acquired from thyroid ultrasonograms in Hashimoto's disease. Biomed Eng Online 2012, 11:48.
65. Beggs A.D., Thomas P.R. Point of use ultrasound by general surgeons: review of the literature and suggestions for future practice. Int J Surg 2013, 11:12-17.
66. Carneiro-Pla D. Ultrasound elastography in the evaluation of thyroid nodules for thyroid cancer. Curr Opin Oncol 2013, 25:1-5.
67. Harvey A.M., Truong L.D., Mody D.R. Diagnostic pitfalls of Hashimoto's/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol 2012, 56:352-360.
68. Yang G.C., Schreiner A.M., Sun W. Can abundant colloid exclude oncocytic (Hurthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hurthle cell) lesions. Cytopathology 2012, 24:185-193.
69. Yazgan A., Balci S., Dincer N., Kiyak G., Tuzun D., Ersoy R., et al. Hurthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology. Cytopathology 2013, (Epub ahead of print).
70. Cibas E.S., Ali S.Z. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009, 132:658-665.
71. Baloch Z.W., LiVolsi V.A., Asa S.L., Rosai J., Merino M.J., Randolph G., et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36:425-437.
72. Rossi E.D., Martini M., Straccia P., Raffaelli M., Pennacchia I., Marrucci E., et al. The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology. An institutional experience. Eur J Endocrinol 2012, 169:649-655.
73. McManus C., Luo J., Sippel R., Chen H. Is thyroidectomy in patients with Hashimoto thyroiditis more risky?. J Surg Res 2012, 178:529-532.
74. Wiersinga W.M. Thyroid hormone replacement therapy. Horm Res 2001, 56(Suppl. 1):74-81.
75. Watanabe T., Maruyama M., Ito T., Fujinaga Y., Ozaki Y., Maruyama M., et al. Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol 2013, 42:325-330.
76. Kohrle J. Selenium and the thyroid. Curr Opin Endocrinol Diabetes Obes 2013, 20:441-448.
77. Eskes S.A., Endert E., Fliers E., Birnie E., Hollenbach B., Schomburg L., et al. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol (Oxf) 2013, (Epub ahead of print).
78. Pearce S.H., Mitchell A.L., Bennett S., King P., Chandran S., Nag S., et al. Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease. J Clin Endocrinol Metab 2012, 97:E1927-E1932.
79. Davies T.F. Is thyroid transplantation on the distant horizon?. Thyroid 2013, 23:139-141.